Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. - Elborn, JS; Horsley, A; MacGregor, G; Bilton, D; Grosswald, R; Ahuja, S; Springman, EB (CTS: Clinical & Translational Science, 2017)